Wyeth Functional Genomics Deal With CAT Valued At $16 Mil.
Executive Summary
Wyeth-Ayerst will pay Cambridge Antibody Technology $4 mil. per year in research funding for up to four years as part of a collaboration aimed at applying CAT's functional genomics technologies to Wyeth targets.